CorWave, a Clichy, France-based company developing cardiac assist devices, raised €26M in second closing of Series C funding.
The round, which brought the total amount to €61M, was led by Bpifrance, with an investment of €15M. European investors and entrepreneurs are investing €11M, including Exor Ventures, controlled by the Agnelli family (Ferrari, Stellantis), and Vlerick Group (textile and metal engineering).
At the first closing of Round C, the company raised €35M from returning investors (Sofinnova Partners, Seventure Partners, Bpifrance, Novo Holdings and Ysios Capital) and new investors (EIC Fund, Arbevel, M&L Healthcare).
The company intends to use the funds to finance the next stages of its development.
Founded in 2021 and led by CEO Louis de Lillers, CorWave is developing cardiac assist devices by leveraging wave membrane technology, which differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart.
FinSMEs
20/06/2023